Intraoperative Imaging Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Intraoperative Imaging Market Trends and Insights

Rising Demand for Minimally Invasive Surgery

The shift from open procedures to minimally invasive surgery remains the clearest volume driver for the intraoperative imaging market because surgeons need live imaging when the operative field is smaller and direct visualization is limited. Intuitive Surgical reported 3,153,000 da Vinci procedures in 2025, up 18% from the prior year, and it expects another 13-15% increase in 2026. That growth rate indicates that robotic and image-guided surgical capacity is still expanding faster than many hospital capital replacement cycles. A 2024 study in the Pakistan Journal of Surgical and Neurological Sciences reported that advanced intraoperative imaging reduced neurological complications to 5.3% from 19.1% and bleeding complications to 2.1% from 7.4% when compared with conventional guidance.^{[2]Advanced Intraoperative Imaging Techniques to Enhance Surgical Precision in Spine Procedures} As hospitals place more weight on measurable outcomes and procedural efficiency, the intraoperative imaging market is likely to see continued demand from centers that want fewer complications, better navigation, and stronger surgeon confidence during technically constrained cases.

AI-Enabled Intraoperative Decision Support

AI is improving the practical value of the intraoperative imaging market by reducing the time between image acquisition and surgical interpretation. A 2026 narrative review reported that Medtronic’s FDA-cleared Spine Smart Dose protocol can reduce radiation dose by 70% versus standard O-arm 3D imaging while maintaining navigation accuracy. The same review described the X23D method, which reconstructs a 3D lumbar vertebra model from 4 intraoperative 2D X-rays in 4 seconds, making advanced navigation more accessible in sites without dedicated intraoperative CT suites. Peer reviewed studies cited in that review also showed that MRI-based synthetic CT can support pedicle screw placement safety comparable to conventional CT, which points to a future pathway with less radiation exposure. A 2025 Journal of Clinical Medicine paper further noted that AI, fluorescence, and extended reality are starting to converge into a single guidance layer, which makes AI a workflow enhancer rather than a separate add-on for the intraoperative imaging market.

Hybrid Operating Room Retrofit Cycles in Tertiary Hospitals

Hybrid operating rooms remain the highest-value setting in the intraoperative imaging market because they combine advanced imaging with open surgery access in one procedural environment. These rooms carry major capital commitments, often in the USD 2-5 million range per suite, yet hospitals continue to back them when they can improve throughput, reduce patient transfers, and support higher-acuity case mix. The intraoperative imaging market is therefore seeing growth not only from new installations, but also from retrofit demand in hospitals that already have active interventional or surgical imaging programs. GE HealthCare’s June 2026 launch of modular Allia upgrade pathways shows how vendors are pursuing this opportunity by modernizing existing interventional suites without full capital displacement. Once a hybrid room is installed, vendors also gain a longer revenue stream from software, service, and follow-on upgrades, which strengthens the commercial case for aggressive competition during the initial tender.

Expansion of Same-Day Complex Procedures in Ambulatory Settings

The movement of more complex procedures into ambulatory settings is creating a new demand layer for the intraoperative imaging market, especially for systems that are compact, fast to position, and simple to integrate. MedPAC reported that 168 new ambulatory surgical centers were certified in 2024, showing that outpatient surgical capacity is still expanding in the United States. This shift matters because many outpatient cases in orthopedics, pain, cardiovascular care, and spine still require dependable imaging even when facilities do not have room for fixed CT or MRI systems. Stryker’s October 2025 launch of IP BRAVoE reflects that change, as the platform was designed for simplified multi-device workflow and real-time decision support in hybrid OR and ASC environments. As outpatient teams stay lean and room turnover becomes more important, the intraoperative imaging market should continue to reward vendors that prioritize portability, ease of use, and workflow integration over maximum hardware complexity.

High Capital and Lifecycle Service Cost

High acquisition and ownership costs remain the most visible barrier in the intraoperative imaging market, especially for modalities at the top end of the capability range. Intraoperative MRI suites can require USD 1-5 million per installation, while O-arm systems typically sit in the USD 750,000-1.2 million range, before service contracts, software licensing, and training are added. These cost layers matter because the buying decision is rarely limited to the scanner alone, and hospitals must account for room design, specialist staffing, maintenance, and downtime exposure. The result is a market where large academic systems can justify premium platforms more easily than mid-tier hospitals, rural buyers, or smaller private groups. This cost gap also favors global OEMs that can spread R&D and service infrastructure over a wider installed base, which keeps the intraoperative imaging market tilted toward scale players in the most advanced product categories.

Reimbursement Pressure on High-Cost Imaging Procedures

Reimbursement pressure narrows the addressable ceiling of the intraoperative imaging market even when clinical interest remains strong. A 2025 PubMed-indexed study found that Medicare reimbursement for imaging modalities declined substantially from 2003 through 2025, with MRI showing the steepest erosion.^{[3]Evolution of Medicare/Medicaid imaging reimbursements from 2003 to 2025} For high-cost intraoperative imaging, hospitals often have to absorb imaging expense inside broader surgical payment bundles, which weakens the payback case for premium platforms. This issue is most relevant for facilities that do not have the procedure mix, surgeon concentration, or financial reserves needed to support high utilization. As AI upgrades and advanced navigation become more central to vendor positioning, the intraoperative imaging market will depend even more on reimbursement models that can recognize the value of better visualization, lower revision risk, and improved operative efficiency.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Mobile C-Arms Anchor Volume as Intraoperative MRI Drives Premium Growth

Mobile C-arms held 42.32% of the intraoperative imaging market size in 2025, making them the largest product category by revenue. Their position reflects broad use across orthopedic, trauma, cardiovascular, and general surgery, where hospitals want versatile systems that fit many rooms and case types. Lower capital cost and a smaller physical footprint also make them easier to adopt than fixed systems, especially in facilities that cannot support dedicated CT or MRI suites. This keeps mobile imaging at the center of the intraoperative imaging market, particularly where hospitals are balancing utilization, room flexibility, and replacement budgets.

The rest of the product mix is moving toward tighter software and navigation integration rather than simple hardware upgrades alone. GE HealthCare’s April 2026 commercial launch of the bkActiv iUS and Medtronic Stealth AXiS digital link shows how ultrasound is gaining relevance by giving surgeons live intraoperative images alongside pre-operative MRI or CT data during cranial procedures. Intraoperative MRI is projected to grow at 7.78% CAGR through 2031, the fastest pace in the product mix, and IMRIS received FDA 510(k) clearance in August 2025 for its InVision 3T Recharge Operating Suite, which lets hospitals upgrade legacy Siemens Magnetom Verio systems to the AI-integrated Skyra Fit platform without reconstructing the facility. Canon Medical’s November 2025 FDA 510(k) clearance for Alphenix 4D CT reinforced the continuing role of intraoperative CT as a strong mid-tier modality inside the intraoperative imaging market.

By Application: Neurosurgery Leads on Share, Spine Surgery On Growth

Neurosurgery accounted for 29.36% of the intraoperative imaging market share in 2025, which kept it as the largest application segment. This leadership is tied to the way brain shift can quickly reduce the accuracy of pre-surgical planning images once the procedure begins. In that setting, surgeons rely on live imaging and navigation as a core part of the procedure rather than an optional support tool. Brainlab’s Elements 7.0 suite received FDA clearance in June 2025 for image fusion, fiber tracking 3.0, and BOLD MRI mapping, which expanded navigation intelligence into functional neurosurgery and strengthened software-led competition inside the intraoperative imaging market.

Other application groups continue to support broad revenue demand, even if they do not lead the share table. Orthopedic and trauma surgery still rely heavily on mobile fluoroscopy, while cardiovascular procedures continue to favor image guidance that can fit both hospital and ambulatory workflows. The May 2026 United States launch of the Aplio i800 EUS Premium Ultrasound System by Olympus and Canon Medical also shows how endoscopic and ultrasound-guided imaging are expanding in gastroenterology and pulmonary applications with AI-supported image enhancement. Spine surgery is projected to grow at 7.33% CAGR through 2031, and Brainlab’s September 2025 FDA 510(k) clearance for Spine Mixed Reality Navigation, together with peer reviewed evidence on MRI-derived synthetic CT for pedicle screw placement, indicates that the intraoperative imaging market is moving toward more immersive and lower-radiation guidance in this segment.

By End User: Hospitals Remain Dominant While ASCs Gain Ground

Hospitals held 63.18% of the intraoperative imaging market share in 2025, which kept them as the dominant end-user group. Their lead reflects access to complex patient volumes, stronger capital budgets, and the ability to support intraoperative CT, intraoperative MRI, and hybrid OR installations under one institutional structure. Academic medical centers sit at the top of this group because they can combine high-acuity case mix with multi-vendor software integration and advanced imaging room design. This makes hospitals the main anchor of the premium intraoperative imaging market, especially for neurosurgery, spine, and image-intensive cardiovascular workflows.

Ambulatory surgical centers are projected to grow at 7.47% CAGR through 2031, making them the fastest-growing end-user category. The end-user mix inside the intraoperative imaging industry is therefore widening, because ASCs increasingly need imaging support for orthopedics, pain care, cardiovascular procedures, and selected spine interventions without the space or shielding needed for the largest fixed systems. Stryker’s October 2025 launch of IP BRAVoE, built to simplify device connectivity and support real-time clinical decisions in hybrid OR and ASC environments, fits that buyer profile and highlights how the intraoperative imaging market is adapting to leaner procedural settings.

Geography Analysis

North America held 42.87% of the intraoperative imaging market size in 2025, which kept it as the largest regional contributor. The United States remains the main driver because the FDA clearance flow in 2025 and 2026 covered major platforms from Brainlab, IMRIS, Canon Medical, and Philips across neurosurgery, spine, MRI, CT, and interventional guidance. This product cycle density gives hospitals more upgrade options and supports faster replacement decisions in modalities where software capability is becoming as important as detector or scanner hardware. 

Europe remained the second-largest regional base in 2025, supported by mature hospitals, established imaging standards, and demand for advanced surgical workflow tools. Philips launched IntraSight Plus in March 2026 after simultaneous FDA 510(k) clearance and CE marking, which shows that Europe continues to matter as a first-wave commercial region for premium guidance platforms. The region also remains important for AI-enabled navigation and dose management, where recent clinical literature has emphasized better reconstruction speed, lower radiation exposure, and closer integration between imaging and guidance layers. CE marking under the Medical Device Regulation framework supports broader commercialization, but the evidence burden around software and algorithm updates will keep vendor execution discipline high inside the intraoperative imaging market.

Asia-Pacific is projected to grow at 7.73% CAGR through 2031, making it the fastest-growing region in the intraoperative imaging market. The growth profile is broader than in North America because it combines first-time placements in expanding surgical centers with selective uptake of premium systems in high-acuity hospitals. This creates room for both mobile C-arm expansion and longer-term demand for integrated navigation, intraoperative CT, and intraoperative MRI platforms.